No matter what stage of product development you’re working on, we have a solution for you.
White Papers
Valuing an Early-Stage Asset in Pharma and Biotech
In 2018, Trinity Life Sciences published a white paper titled, How to Approach Asset Valuation in Pharma & Biotech: Putting a price tag on emerging therapies. At the time, pharma and biotech firms were seeing venture investment growth of ~20% per year. This trend has only accelerated alongside the value of co-developments, partnerships, joint ventures, […]
Read More
Briefs
Capitalizing on Opportunities to Drive Impact in Commercial Operations
Throughout the first half of 2022, we’ve continued to face historic, unprecedented challenges related to the ongoing global pandemic. Life sciences enterprises, and essentially all industries, are grappling with decisions large and small. Priorities for Commercial, Market Access and Medical Affairs organizations in the life sciences industry continue to shift as teams work feverishly to […]
Read More
White Papers
Empowering the Next-Generation Launch Model
The pharma industry has seen dramatic shifts in scientific innovation over the last decade with a trend toward orphan markets, personalized medicine, higher priced products and new modalities including cell and gene therapies, oligonucleotides and others. COVID served to further accelerate scientific innovation, driving a near record-breaking number of FDA approvals, astronomical venture capital funding […]
Read More
Director,
Head of Quantitative Insights
Clive designs and applies sound market research methodologies and analytics to generate meaningful insights of commercial importance to the industry. His research expertise spans all facets of commercial development and across many disease areas. Clive leads the research innovation team at Trinity with a continued focus on bringing academic rigor to our research projects and […]
Principal
Caroline has a decade of life sciences consulting experience with Trinity, partnering with life science clients to generate evidence-based insights that enable strategic decision making. Her specialty lies in partnering with companies focused on commercial assessments, BD/NPP strategy, pipeline/portfolio prioritization and strategy, bringing deep expertise in rare diseases, pulmonology and immunology. Caroline earned a healthcare […]
Senior Vice President, Commercial Operations Management Advisor
John works with commercial operations leaders within the top 35 pharmaceutical/biotech companies to optimize existing commercial operations departments. In addition, he has established new central departments in companies where none previously existed in pre-commercial to Top 10 firms. John’s 20+ years in the industry has positioned him to respond to the needs of pharmaceutical clients. […]
Senior Partner,
Insights
Aparna leads the design and execution of primary market research projects in support of Trinity’s consulting engagements. She specializes in shaping therapeutic area commercial strategy through insights and analytics across multiple disease areas. Aparna’s focus is on helping clients identify the “right” business questions, developing a hypothesis-based approach to address the question and leveraging her […]
Senior Vice President, Emerging Life Sciences Network
Curt has over 30 years of experience on both the consulting and client side. He currently leads the TGaS Emerging Life Sciences Network focused on supporting pre-commercial and emerging companies. Recently, Curt has created the TGaS Chief Commercial Officers Network which provides a forum for CCO’s to address common issues and challenges. During his time at […]
Partner
Amanda has been a key leader of Trinity’s strategic advisory group for a decade. Known for her expertise in new product planning, strategic business development and L&A work, Amanda also specializes in leading large, integrated projects that involve strategic advisory services, primary market research, and secondary data analytics. Over nearly a dozen years, she has […]
Principal &
Head of Patient Centricity
Jennifer currently leads Trinity’s Patient Centricity Center of Excellence, helping Trinity’s clients weave the Voice of the Patient into all facets of the product lifecycle. Jennifer’s group works closely with Trinity’s Strategic Advisory, PMR and RWE teams to produce deep patient insights based in real-world data, that are tactically actionable for a wide range of […]
